193 related articles for article (PubMed ID: 24825466)
1. Gout patients have an increased risk of developing most cancers, especially urological cancers.
Chen CJ; Yen JH; Chang SJ
Scand J Rheumatol; 2014; 43(5):385-90. PubMed ID: 24825466
[TBL] [Abstract][Full Text] [Related]
2. Allopurinol and the incidence of bladder cancer: a Taiwan national retrospective cohort study.
Chen CJ; Hsieh MC; Liao WT; Chan YT; Chang SJ
Eur J Cancer Prev; 2016 May; 25(3):216-23. PubMed ID: 25830898
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune disease and subsequent urological cancer.
Liu X; Ji J; Forsti A; Sundquist K; Sundquist J; Hemminki K
J Urol; 2013 Jun; 189(6):2262-8. PubMed ID: 23228387
[TBL] [Abstract][Full Text] [Related]
4. Association of metabolic syndrome and its components with the risk of urologic cancers: a prospective cohort study.
Jiang R; Wang X; Li Z; Cai H; Sun Z; Wu S; Chen S; Hu H
BMC Urol; 2023 Sep; 23(1):150. PubMed ID: 37736725
[TBL] [Abstract][Full Text] [Related]
5. Increasing occurrence of urological cancers in Slovakia.
Plesko I; Obsitnikova A; Cuninkova M; Tomasek L; Stefanakova D; Kubik A
Neoplasma; 2004; 51(4):248-54. PubMed ID: 15254654
[TBL] [Abstract][Full Text] [Related]
6. Gout: an independent risk factor for all-cause and cardiovascular mortality.
Kuo CF; See LC; Luo SF; Ko YS; Lin YS; Hwang JS; Lin CM; Chen HW; Yu KH
Rheumatology (Oxford); 2010 Jan; 49(1):141-6. PubMed ID: 19933595
[TBL] [Abstract][Full Text] [Related]
7. [De novo urological neoplasms in kidney transplant patients: experience in 1,751 patients].
di Capua Sacoto C; Luján Marco S; Bahilo Mateu P; Budía Alba A; Pontones Moreno JL; Jiménez Cruz JF
Actas Urol Esp; 2010 Jan; 34(1):88-94. PubMed ID: 20223138
[TBL] [Abstract][Full Text] [Related]
8. Global Burden of Urologic Cancers, 1990-2013.
Dy GW; Gore JL; Forouzanfar MH; Naghavi M; Fitzmaurice C
Eur Urol; 2017 Mar; 71(3):437-446. PubMed ID: 28029399
[TBL] [Abstract][Full Text] [Related]
9. Family history of urogenital cancers in patients with bladder, renal cell and prostate cancers.
Randi G; Pelucchi C; Negri E; Talamini R; Galeone C; Franceschi S; La Vecchia C
Int J Cancer; 2007 Dec; 121(12):2748-52. PubMed ID: 17724720
[TBL] [Abstract][Full Text] [Related]
10. Role of C-reactive protein in urological cancers: a useful biomarker for predicting outcomes.
Saito K; Kihara K
Int J Urol; 2013 Feb; 20(2):161-71. PubMed ID: 22897628
[TBL] [Abstract][Full Text] [Related]
11. Association between colorectal cancer and urologic cancers.
Calderwood AH; Huo D; Rubin DT
Arch Intern Med; 2008 May; 168(9):1003-9. PubMed ID: 18474765
[TBL] [Abstract][Full Text] [Related]
12. Risk of urinary tract cancers following kidney or ureter stones.
Chow WH; Lindblad P; Gridley G; Nyrén O; McLaughlin JK; Linet MS; Pennello GA; Adami HO; Fraumeni JF
J Natl Cancer Inst; 1997 Oct; 89(19):1453-7. PubMed ID: 9326915
[TBL] [Abstract][Full Text] [Related]
13. Physical activity and urologic cancers.
Wolin KY; Stoll C
Urol Oncol; 2012 Sep; 30(5):729-34. PubMed ID: 23021556
[TBL] [Abstract][Full Text] [Related]
14. Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.
Liauw SL; Sylvester JE; Morris CG; Blasko JC; Grimm PD
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):669-73. PubMed ID: 16887293
[TBL] [Abstract][Full Text] [Related]
15. Higher than expected association of clinical prostate and bladder cancers.
Singh A; Kinoshita Y; Rovito PM; Landas S; Silberstein J; Nsouli I; Wang CY; Haas GP
J Urol; 2005 May; 173(5):1526-9. PubMed ID: 15821472
[TBL] [Abstract][Full Text] [Related]
16. Urinary tract cancer and hereditary nonpolyposis colorectal cancer: risks and screening options.
Sijmons RH; Kiemeney LA; Witjes JA; Vasen HF
J Urol; 1998 Aug; 160(2):466-70. PubMed ID: 9679899
[TBL] [Abstract][Full Text] [Related]
17. Risk of incident benign prostatic hyperplasia in patients with gout: a retrospective cohort study.
Li WM; Pasaribu N; Lee SS; Tsai WC; Li CY; Lin GT; Chuang HY; Tung YC; Tu HP
Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):277-286. PubMed ID: 29858589
[TBL] [Abstract][Full Text] [Related]
18. [Descriptive epidemiology of urologic cancers].
Schaffer P; Lavillaureix P; Bollack C
J Urol (Paris); 1984; 90(7):475-82. PubMed ID: 6530561
[TBL] [Abstract][Full Text] [Related]
19. Association between gout and vertigo in a Taiwanese population.
Lin YT; Lin HW; Huang YC; Ho WT; Li YC; Chen TJ
J Clin Neurosci; 2013 Jun; 20(6):857-61. PubMed ID: 23394876
[TBL] [Abstract][Full Text] [Related]
20. Risk of prostate and bladder cancers in patients with spinal cord injury: a population-based cohort study.
Lee WY; Sun LM; Lin CL; Liang JA; Chang YJ; Sung FC; Kao CH
Urol Oncol; 2014 Jan; 32(1):51.e1-7. PubMed ID: 24239459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
